San Diego-based CureScience Institute, a non-profit organization dedicated to accelerating novel curative therapies, disclosed on Tuesday that Dr Boris Reznik has been appointed as an Advisory Board member.
Dr Reznik is chairman of Venvalo Group, venture value optimization firm and is a veteran of several startups.
According to CureScience Institute, Dr Reznik has a strong track record of building companies across a diverse set of technologies-based industries, primarily focused on biomedical sciences.
CEO of CureScience Institute, Dr Shashaanka Ashili, commented: "I am delighted to welcome Dr Reznik to our Advisory Board," adding "He brings a unique experience in accelerating drug and device development for life sciences companies. We at CureScienceTM look forward to benefiting from Dr Reznik's counsel as we work towards developing personalized therapeutic approaches."
Clinical Laserthermia Systems applies for CE marking of ClearPoint Prism neuro laser system
Bonesupport shifts CERAMENT V review to FDA's De Novo pathway
Neola Medical secures US patent for disposable lung monitoring probes
Remington Medical's VascuChek 2.0 Cordless Bluetooth-Enabled Doppler Secures FDA Clearance
Aetna to launch generative AI-powered conversational experience
Maxx Orthopedics Receives FDA 510(k) Clearance for Its Libertas® Bipolar Hip System
Ascletis Pharma announces ASC36 and ASC35 co-formulation for clinical development
Adocia files patent for long-acting peptide platform AdoXLong and updates on BioChaperone studies
Nurami Medical completes Phase 1 milestones in EIC-backed grant for Artifix